Legislation & Events

FDA's New Plan for Tobacco and Nicotine Regulation

On July 28, the FDA announced a new comprehensive plan which places nicotine, and the issue of addiction, at the center of the agency's tobacco regulation efforts. This plan will serve as a multi-year roadmap to better protect kids and significantly reduce tobacco-related disease and death.

A key piece of the approach is demonstrating a greater awareness that nicotine—while highly addictive—is delivered through products that represent a continuum of risk and is most harmful when delivered through smoke particles in combustible cigarettes. Accordingly, the FDA is announcing several efforts to shift the trajectory of tobacco-related disease and death.

To read the full article, visit the FDA's website
https://www.fda.gov/TobaccoProducts/NewsEvents/ucm568425.htm

FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death

On July 28, the FDA announced a new comprehensive plan which places nicotine, and the issue of addiction, at the center of the agency's tobacco regulation efforts. This plan will serve as a multi-year roadmap to better protect kids and significantly reduce tobacco-related disease and death.

A key piece of the approach is demonstrating a greater awareness that nicotine—while highly addictive—is delivered through products that represent a continuum of risk and is most harmful when delivered through smoke particles in combustible cigarettes. Accordingly, the FDA is announcing several efforts to shift the trajectory of tobacco-related disease and death.

To read the full article, visit the FDA's website
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm568923.htm

Final Rule: Clarification of When Products Made or Derived From Tobacco Are Regulated as Drugs, Devices, or Combination Products

FDA's approach to regulating tobacco products is grounded in science and uses the full power of the law to protect public health.

To read the full article, visit the FDA's website
https://www.fda.gov/TobaccoProducts/Labeling/default.htm

Senate confirms e-cig industry’s friend Gottlieb as FDA chief

Scott Gottlieb
Scott Gottlieb

Scott Gottlieb, who plans a review of the deeming regulation that has caused so much concern for the e-cigarette industry, is set to become the next commissioner of the U.S. Food and Drug Administration (FDA) after winning Senate confirmation.

With little drama and even less doubt, senators voted 57 to 42 for confirmation, with five Democrats and one Independent who caucuses with the minority party siding with the Republican majority.

That bi-partisan victory for President Donald Trump, who nominated Gottlieb in March, was significant because of the many questions triggered by the nominee's deep ties to drug companies and others that fall under the FDA's jurisdiction....

To read the full article, visit e-Cig Intelligence's website
https://www.fda.gov/TobaccoProducts/NewsEvents/ucm568425.htm

Industry association trains its sights on cowboy firms and battery safety

A new U.S. industry association used last week's Food and Drug Administration (FDA) workshop on e-cigarette batteries as the platform to announce its own launch.

The non-profit Global Vaping Standards Association (GVSA) was created to help consumers tell which suppliers play by the rules and which do not, according to James Xu, CEO of Avail Vapor, and Patrice Carroll, executive director of the new association....

To read the full article, visit e-Cig Intelligence's website
http://ecigintelligence.com/industry-association-trains-its-sights-on-cowboy-firms-and-battery-safety/

After writing a letter to President Trump, Rep Duncan Hunter turns to media to explain why e-cigarette rules in the USA are going the wrong way.

Read Full Article

Congressman Duncan Hunter Vapes during Congressional Hearing in support of the industry

AmeriNic
Aspire
Avail Vapor
Eve Battery
Innokin
Joyetech
Kranger Tech
Smok
Smoore